. OBs in the trabecular bone area were shown to express high levels of Jagged-1, and support a higher frequency of HSCs in these regions 5 . Increased numbers of spindle-shaped N-cadherin+ CD45-osteoblastic cells following conditional inactivation of BMP correlated with an increase in HSC numbers 6 .
Similarly, CD166 expressing OB were reported to play an important role in supporting quiescent long-term repopulating cells 7, 8 . Other studies, however, have not supported an essential role for OBs in HSC maintenance. Calvi et al. reported in a follow up study that in vivo parathyroid hormone induced expansion of mature OBs and osteocytes did not lead to increased HSCs 9 .
required for HSC regulation, do not rule out a role for other OB mediated mechanisms in HSC regulation. Indeed, it is possible that the interaction of several BM microenvironmental populations may be required for HSC maintenance 12, 13 .
Several leukemias, including chronic myelogenous leukemia (CML) are maintained by a pool of leukemia stem cells (LSCs) within the BM 14, 15, 16 . As with normal HSCs, LSCs are also thought to localize to specific niches in the BM microenvironment that support their growth and maintenance and may protect them from therapeutic exposures. In addition, leukemic induced alterations in the BM microenvironment may lead to altered niche function, 17 Supplementary Table S1 .
Bone marrow morphology and immunohistochemistry
Following GCV treatment, femurs were collected, incubated in 10% formalin for 24-48 hours, decalcified for 3 hours, and washed under running water for 1 hour. Following additional formalin incubation femurs were dehydrated and incubated and blocked in paraffin for microtome sectioning. Representative sections were baked to remove excess paraffin, stained with hematoxylin and eosin, and imaged. Immunohistochemistry was used to visualize GFPexpressing cells, following deparaffinization, antigen retrieval and anti-GFP antibody labeling.
For personal use only. on October 4, 2017. by guest www.bloodjournal.org From Endogenous peroxidase activity was quenched followed by blocking using Block Aid Blocking Solution (Invitrogen B10710 and Triton X-100). Slides were incubated with primary mouse anti-GFP antibody (Abcam ab290, 1:200) overnight at 4°C, followed by secondary biotinylated antirabbit antibody (Vector,1:1000) for one hour at room temperature. The Vectastain ABC Elite kit (Vector, PK-6100) was used for antigen visualization. Slides were counterstained with hematoxylin and coverslipped in Cytoseal 60 (Richard-Allan Scientific, 8310-16). Bright field microscopy was performed using a Nikon TE2000-U microscope. Images were captured and processed using a SPOT RT Slider digital camera and software (Diagnostic Instruments, Sterling Heights, MI).
Analysis of hematopoietic cells by flow cytometry
BM (femurs and tibias), spleens (SP) and peripheral blood (PB) were collected from GCV-treated mice. For analysis of OB numbers, pelvic bones were also collected. Bones were crushed, digested with collagenase for 45 minutes at 37°C, and cells isolated and counted prior to staining with fluorescent antibodies for flow cytometry. All analyses were performed on a LSRII flow cytometer (BD Biosciences). Stem and progenitor populations were identified as: 
Homing assay
Lin-donor cells from the BM of control mice (CD45.1) were transplanted into CD45.2 TK-and TK+ recipient mice that had been treated with GCV for 28 days (irradiated 900 rads, 1x10 6 Lin-cells/mouse). Engraftment of CD45.1+ donor nucleated cells, LSK and LTHSC in the BM of recipient mice was analyzed at 16 hours post transplantation by flow cytometry.
Statistics
Results are displayed as means ± standard errors of the means (SEM). Significance values for differences between groups were calculated using GraphPad Prism software using unpaired, non-parametric t-tests (Mann Whitney test) or 2-way ANOVA. Survival was analyzed using Kaplan Meyer curve analysis.
Results

Confirmation of OB ablation
The Col2.3Δtk mouse model allows OB-specific expression of HSV and spleen ( Figure 2G ) of GCV treated TK+ mice. Importantly, a highly selected LTHSC subpopulation lacking CD229 expression, LSK Flt3-CD34-CD49b-CD229-, was significantly reduced in TK+ mice ( Figure 2H ).
Effects of OB ablation on BM hematopoietic stem cell function
To evaluate BM hematopoietic function, whole BM cells (8, These results indicate that LTHSCs from OB ablated mice demonstrate reduced quiescence and impaired long-term regenerative and self-renewing capacity.
We also evaluated homing of normal HSC to the BM of OB ablated mice. BM cells from normal mice (CD45.1) were transplanted intravenously into TK-and TK+ mice (CD45. 2) that had been treated with GCV for 4 weeks. Engraftment of donor cells was analyzed after 16 hours. No significant differences in Lin-, LSK or LTHSC engraftment in BM of TK+ or TK-mice, indicating that OB ablation does not affect homing of LTHSC in BM ( Figure S6C ).
Effect of OB ablation on leukemic hematopoiesis
To examine how OB ablation may affect leukemic hematopoiesis, we used transgenic SCL-tTA/BCR-ABL mice, which provide a representative model of human chronic phase CML. Figure 5A ). To examine the effect of OB ablation on CML development, BCR-ABL TK+ and TK-mice were treated with GCV for one week to initiate OB ablation, followed by tetracycline withdrawal to induce BCR-ABL expression, with continuing daily GCV administration. Leukemia development was monitored by examining blood counts every 2 weeks ( Figure 5B ). OB ablated mice demonstrated enhanced neutrophilic leukocytosis at 6 weeks post-induction compared to non-ablated CML mice ( Figure 5C ). Mice were followed for survival until all GCV treated BCR-ABL + TK+ mice were deceased. Kaplan Meyer analysis demonstrated significantly decreased survival of OB ablated CML mice compared to controls ( Figure 5D ). These results indicate that OB ablation results in accelerated leukemia development.
We compared the ability of LSC from OB ablated and non-ablated CML mice to engraft and generate leukemia after transplantation. LTHSC populations isolated from BCR-ABL+ TK+ and TK-mice (CD45.2) treated with GCV for 4 weeks were transplanted into CD45.1 recipient mice (400 cells/mouse). We observed increased survival of mice receiving LTHSC from OB ablated BCR-ABL mice compared to control mice ( Figure 5E ), with reduced neutrophilic leukocytosis ( Figure 5F ). These results indicate that LTHSC from OB ablated BCR-ABL mice show reduced long-term engraftment and leukemogenic capacity after transplantation.
Role of Jagged-1 in regulating normal and CML LTHSC growth
Jagged-1 expressed on OBs has been reported to contribute to maintenance of HSC repopulating capacity 5 . Recently, expression of an activated β -catenin mutant in OB was reported to induce expression of Jagged-1 in OB, activate Notch signaling in HSC, and promote development of AML 23 . We therefore analyzed expression of Jagged-1 in OBs from normal and CML mice, and its role in regulating normal and BCR-ABL+ LTHSC growth. Jagged-1 mRNA expression was increased in OB purified from CML mice compared to normal mice ( Figure 6A ).
To evaluate response to Jagged-1 exposure, normal and BCR-ABL+ LTHSC were cultured with Our results support a role for OBs in regulating the long-term self-renewal potential of LTHSCs. Previous reports indicated a more severe phenotype of GCV treated TK+ mice with loss of lymphoid, erythroid, and myeloid progenitors in the BM, decrease in HSC numbers, and increased extramedullary hematopoiesis 3, 21 . These studies were performed in CD-1/ICR mice and it is possible the severity of the phenotype observed is strain dependent. The milder phenotype observed here is consistent with reports indicating the importance of other BM niches in HSC maintenance. Deletion of SCF or CXCL12 from OB did not affect LTHSC maintenance and instead supported a critical role for endothelial and perivascular mesenchymal cells in HSC maintenance 10, 11 . However, other OB mediated regulatory mechanisms could contribute to HSC maintenance. Indeed, multiple niche cells may cooperate to provide signals required for HSC maintenance 12, 13 .
Reduced HSC self-renewal in OB ablated mice may be related to loss of LTHSC quiescence. It has been reported that OBs in trabecular bone area express high levels of Jagged-1, which interacts with Notch ligand on HSCs. HSCs that are not bound to Jagged-1 5 . Our studies indicate that Jagged-1 inhibits LTHSC entry into cell cycle. Loss of Jagged-1 induced signaling may contribute to loss of LTHSC quiescence following OB ablation. However other mechanisms could also contribute. CD166 or Activated
Leukocyte Cell Adhesion Molecule receptor (ALCAM) is expressed on both HSCs and OBs and may support self-renewal of long-term repopulating cells 7, 8, 24 . OB ablation could also indirectly affect HSC function by affecting other hematopoietic niche components 1 . The physical change to the endosteal region upon OB ablation could impact the way LTHSCs are able to interact with other niche components. Finally, the GCV used to induce OB ablation generates a toxic thymidine analogue through interaction with Δ TK. Although we cannot rule out the possibility that the toxic thymidine analogue could have affected surrounding cells, this appears unlikely since total LTHSC numbers were not reduced, and instead were increased after OB ablation.
The enhanced leukocytosis and decreased overall survival observed following OB ablation in CML mice supports a role for OBs in regulating CML LSC proliferation, inhibiting leukemia development in primary CML mice. These observations are consistent with studies using a transduction-transplantation model of CML that indicate that increased OB development and bone remodeling following parathyroid hormone administration was associated with decreased LSC proliferation 25 . Interestingly, Jagged-1 was overexpressed in OB from BCR-ABL compared to normal mice. As with normal LTHSC, Jagged-1 exposure inhibited cell cycling of BCR-ABL LTHSC, suggesting that loss of Jagged-1 signaling could contribute to accelerated leukemia development following OB ablation. The role of OB-mediated Jagged-1 signaling in CML LSC regulation and persistence warrants further investigation in future studies. We alos observed that LSC from OB ablated mice demonstrated impaired capacity to generate leukemia in secondary recipients after transplantation. Although the underlying mechanisms are unclear, one possible explanation could be reduced LSC self-renewal related to increased proliferation.
However reduced leukemogenicity in secondary recipients could be related to functional alterations in LSC homing and engraftment properties following OB ablation. It will be of interest
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In conclusion, our studies provide new insights into the role of the OB niche in maintaining long-term self-renewal of normal HSCs and in regulating CML LSCs to modulate leukemia evolution. These studies support further efforts to elucidate OB induced signals modulating HSC self-renewal, and OB alterations and signaling in leukemia. D.
E.
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